Invenomic Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001769456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q2 2024 · 158 positions · Total reported value $2.05B · Top-10 concentration 26.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.9% · 35 new · 31 cut · 35 exited

Active Share (vs S&P 500): 99.0% · vs QQQ: 99.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.7% · vs SPY +0.6% · Prev Value $1.67B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +8.2% · vs SPY +6.1% · Latest Value $2.02B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, Invenomic Capital Management LP disclosed 158 equity positions with a combined reported value of $2.05B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 26.5% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q2 2024 were SPY ($136.06M), ES ($55.23M), CHRD ($47.91M). By sector, the heaviest allocations are Consumer Discretionary 23.0%, Technology 16.5%. Versus the prior quarter, allocation shifted toward Communication Services (+5.3pp), Health Care (+1.9pp) and away from Utilities (-0.6pp), Energy (-0.8pp).

Versus the prior quarter, Invenomic Capital Management LP opened 35 new positions, trimmed 31 and fully exited 35, a turnover rate of 66.9% of positions. The portfolio's overlap with the prior quarter was 59% of names.

The largest new positions opened in Q2 2024 were SPY ($136.06M), SOLV ($43.58M), APTV ($26.64M).

Of the 35 positions fully exited versus the prior quarter, the largest were ADM ($37.92M), CAG ($25.15M), WEX ($23.03M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • SPY STATE STR SPDR S&P 500 ETF T · $136.06M
  • SOLV SOLVENTUM CORP · $43.58M
  • APTV APTIV PLC · $26.64M
  • NEM NEWMONT CORP · $23.77M
  • NTR NUTRIEN LTD · $21.15M
  • DNB DUN & BRADSTREET HLDGS INC · $18.97M
  • COUR COURSERA INC · $18.03M
  • MTCH MATCH GROUP INC NEW · $13.86M

Fully Exited (vs previous quarter)

  • ADM ARCHER DANIELS MIDLAND CO · prev qtr: $37.92M
  • CAG CONAGRA BRANDS INC · prev qtr: $25.15M
  • WEX WEX INC · prev qtr: $23.03M
  • SMAR SMARTSHEET INC · prev qtr: $21.93M
  • CPG CRESCENT PT ENERGY CORP · prev qtr: $17.17M
  • CVS CVS HEALTH CORP · prev qtr: $15.15M
  • ALE ALLETE INC · prev qtr: $14.96M
  • AEE AMEREN CORP · prev qtr: $14.36M

Insider Transactions (Form 4)

Latest Invenomic Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Invenomic Capital Management LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q3 2026 it reported 116 US equity positions with a combined value of $2.02B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-110459 (status: Approved), registered 2017-04-20
  • Regulatory AUM (Form ADV): $3.39B as of 2026-03-31
  • Client mix (by RAUM): registered investment companies 60%, pension and profit-sharing plans 40%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 116 positions · $2.02B reported value (Q3 2026)
  • Top 10 holdings = 29.4% of reported value
  • Largest position: UHS (UNIVERSAL HLTH SVCS INC) at 3.9%
  • Average position size: $17.43M

Sector Tilt

  • Consumer Discretionary 28.5%
  • Information Technology 26.1%
  • Industrials 14.9%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q3 2026: 35 new, 45 added, 31 reduced, 35 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 16.5%
Health Care 10.4%
Energy 6.6%
Utilities 4.2%
Other 27.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 250.00K $136.06M 6.62%
6.62%
New
2 973.99K $55.23M 2.69%
2.69%
Add
3 285.74K $47.91M 2.33%
2.33%
Reduce
4 476.41K $46.07M 2.24%
2.24%
Add
5 2.40M $45.95M 2.24%
2.24%
Reduce
6 4.29M $45.61M 2.22%
2.22%
Add
7 824.18K $43.58M 2.12%
2.12%
New
8 733.26K $43.40M 2.11%
2.11%
Add
9 659.11K $41.31M 2.01%
2.01%
Reduce
10 6.75M $38.43M 1.87%
1.87%
Add
11 914.76K $37.72M 1.84%
1.84%
Add
12 790.42K $37.05M 1.80%
1.80%
Add
13 546.71K $32.25M 1.57%
1.57%
Add
14 253.51K $31.94M 1.55%
1.55%
Add
15 303.59K $31.69M 1.54%
1.54%
Add
16 764.41K $28.58M 1.39%
1.39%
Reduce
17 182.84K $27.67M 1.35%
1.35%
Add
18 462.97K $26.87M 1.31%
1.31%
Reduce
19 378.31K $26.64M 1.30%
1.30%
New
20 1.37M $26.50M 1.29%
1.29%
Reduce
21 368.40K $25.42M 1.24%
1.24%
Reduce
22 219.86K $25.37M 1.24%
1.24%
Reduce
23 2.91M $25.14M 1.22%
1.22%
Add
24 2.93M $24.42M 1.19%
1.19%
Reduce
25 1.64M $24.32M 1.18%
1.18%
Reduce
26 567.75K $23.77M 1.16%
1.16%
New
27 1.44M $23.73M 1.16%
1.16%
Add
28 662.56K $22.39M 1.09%
1.09%
Reduce
29 2.07M $22.30M 1.08%
1.08%
Add
30 564.89K $21.86M 1.06%
1.06%
Reduce
31 10.94M $21.34M 1.04%
1.04%
Add
32 415.52K $21.15M 1.03%
1.03%
New
33 894.39K $20.56M 1.00%
1.00%
Add
34 2.05M $18.97M 0.92%
0.92%
New
35 1.12M $18.61M 0.91%
0.91%
Reduce
36 446.37K $18.41M 0.90%
0.90%
Add
37 2.45M $18.21M 0.89%
0.89%
Add
38 2.52M $18.03M 0.88%
0.88%
New
39 183.22K $17.95M 0.87%
0.87%
Add
40 2.58M $17.81M 0.87%
0.87%
Add
41 551.41K $17.77M 0.86%
0.86%
Add
42 1.61M $17.27M 0.84%
0.84%
Add
43 233.37K $17.27M 0.84%
0.84%
Add
44 678.63K $16.91M 0.82%
0.82%
Reduce
45 2.12M $15.80M 0.77%
0.77%
Reduce
46 287.39K $14.72M 0.72%
0.72%
Add
47 271.66K $14.59M 0.71%
0.71%
Reduce
48 760.06K $14.19M 0.69%
0.69%
Reduce
49 456.13K $13.86M 0.67%
0.67%
New
50 523.13K $13.43M 0.65%
0.65%
Add

FAQ

What did Invenomic Capital Management LP buy in 2024-Q2?

In its 2024-Q2 13F filing, Invenomic Capital Management LP reported 158 equity positions worth $2.05B in aggregate; its largest disclosed positions were SPY ($136.06M), ES ($55.23M), CHRD ($47.91M).

How large is Invenomic Capital Management LP's portfolio?

Invenomic Capital Management LP reported $2.05B of long equity holdings across 158 positions as of 2024-Q2. Top-10 holdings account for 26.5% of reported value.

What is Invenomic Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/invenomic-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →